AmerisourceBergen

AmerisourceBergen
BillCramer · CC BY-SA 4.0 · source
Name	AmerisourceBergen
Type	Public
Industry	Pharmaceuticals
Founded	2001
Headquarters	Conshohocken, Pennsylvania, United States
Products	Pharmaceutical distribution, consulting

AmerisourceBergen is a global pharmaceutical sourcing and distribution company engaged in the procurement, distribution, and consulting for pharmaceutical manufacturers, pharmacies, hospitals, and health systems. Founded through a merger in the early 21st century, the company operates within international supply chains serving stakeholders across North America, Europe, and other regions, interacting with prominent manufacturers, health systems, and regulatory institutions. Its activities connect it to notable corporations, healthcare providers, industry associations, and legal proceedings that have shaped contemporary pharmaceutical distribution.

History

The company was created in 2001 by the merger of two major distributors, combining the corporate lineages of entities linked to Rite Aid, McKesson Corporation, Walgreens Boots Alliance, Cardinal Health, and earlier distributors whose histories intersect with firms such as Bristol-Myers Squibb and Pfizer. Early growth involved strategic alliances and acquisitions involving international players like Boots Group, Celesio, and Walgreens. In the 2000s and 2010s expansion included acquisitions and partnerships tying the company to manufacturers including Novartis, Roche, AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, and Johnson & Johnson. Corporate developments brought interactions with investors and advisors such as BlackRock, The Vanguard Group, Goldman Sachs, and Morgan Stanley. The company’s timeline also intersected with regulatory milestones involving agencies like the Food and Drug Administration, Drug Enforcement Administration, and international regulators such as the European Medicines Agency.

Business operations

Operations center on pharmaceutical distribution, specialty pharmaceutical services, oncology and oncology support, and consulting services for health systems and manufacturers, linking operational workflows to partners including CVS Health, Kaiser Permanente, Intermountain Healthcare, Mayo Clinic, and Cleveland Clinic. The company’s supply chain logistics tie into cold chain technologies developed with firms comparable to Thermo Fisher Scientific, GE Healthcare, and Siemens Healthineers, and utilize enterprise resource planning systems from providers like SAP SE and Oracle Corporation. Commercial relationships span generic and branded manufacturers including Teva Pharmaceutical Industries, Mylan (Viatris), Bayer, Sanofi, Takeda Pharmaceutical Company, and contract manufacturers associated with Catalent and Lonza Group. Distribution channels encompass community pharmacies, specialty pharmacies, hospitals, long-term care providers, and veterinary outlets, intersecting with networks like Medicare and payer systems such as UnitedHealth Group and Centene Corporation.

Corporate governance and leadership

Corporate leadership has included executives and board members with prior roles at institutions such as Procter & Gamble, General Electric, ExxonMobil, and Johnson & Johnson, while board composition has reflected ties to investment firms such as Berkshire Hathaway-adjacent directors, activist investors including Elliott Management Corporation, and governance advisors from Glass Lewis and Institutional Shareholder Services. Governance frameworks align with listing requirements of New York Stock Exchange and financial oversight by auditors from the network of PricewaterhouseCoopers, Ernst & Young, KPMG, and Deloitte. Executive succession and compensation discussions have drawn attention from proxy advisory firms and institutional owners including CalPERS and TIAA.

Financial performance

The company’s financial statements and performance metrics have been tracked alongside peers such as Cardinal Health and McKesson Corporation in analyses by Standard & Poor's, Moody's Investors Service, and Fitch Ratings. Revenue trends have mirrored pharmaceutical market shifts influenced by patent cliffs at firms like Merck & Co. and AbbVie, pricing dynamics debated in legislative venues such as the U.S. Congress and market pressures from wholesale adjustments involving Costco and Walmart. Capital markets activity has involved bond issuances underwritten by banks such as JPMorgan Chase, Bank of America, and Citigroup, and equity dynamics reflected in indices like the S&P 500 and Dow Jones Industrial Average coverage by analysts at Goldman Sachs and Morgan Stanley.

Legal issues and controversies

The company has been a party to litigation and regulatory scrutiny connected to opioid distribution, agreements involving state attorneys general including those from Ohio Attorney General, Massachusetts Attorney General, and multi-state settlements coordinated with offices like the U.S. Department of Justice and the U.S. Department of Health and Human Services. High-profile cases referenced municipal plaintiffs such as Sackler-related litigation tied to manufacturers like Purdue Pharma and bankruptcy proceedings in courts overseen by judges from the United States Bankruptcy Court. Other proceedings involved compliance reviews by the Drug Enforcement Administration, investigations tied to distribution channels used by pharmacies such as Walgreens and Rite Aid, and antitrust matters examined by the Federal Trade Commission and the U.S. Department of Justice Antitrust Division.

Corporate responsibility and sustainability

Corporate responsibility initiatives have included programs addressing drug take-back partnerships with local governments like New York City, public health collaborations with organizations such as the Centers for Disease Control and Prevention, and philanthropy associated with health foundations like the Bill & Melinda Gates Foundation and Robert Wood Johnson Foundation. Sustainability reporting aligns with frameworks promoted by the Sustainability Accounting Standards Board and commitments referencing international standards such as the United Nations Global Compact and the Task Force on Climate-related Financial Disclosures. Workforce and community engagement efforts connect the company to labor organizations and training partners including Teamsters-affiliated entities, professional groups like the American Hospital Association, and academic collaborators at institutions such as Johns Hopkins University and Harvard Medical School.

Category:Pharmaceutical distribution companies